Literature DB >> 35286696

The Immunogenetics of Morphea and Lichen Sclerosus.

Pooya Khan Mohammad Beigi1.   

Abstract

Morphea and lichen sclerosis et atrophicus (LSA) are two distinct immune-mediated diseases with a dominant presentation of dermal fibrosis and sclerosis. The two diseases have many similar clinical and histological features and tend to co-occur. Both diseases are thought to result from a derailment of the normal response to environmental triggers. Positive family history is more common in LSA than morphea but individuals with morphea have a higher frequency of concomitant and familial autoimmunity. These findings hint at the involvement of inheritance in susceptibility to LSA and morphea and thus provide a rationale for exploring the disease genetics. This chapter contains a comprehensive review of the pathogenesis of the two diseases and their known genetic associations including HLA class I and II genes.
© 2022. Springer Nature Switzerland AG.

Entities:  

Keywords:  Immunogenetics; Lichen sclerosus; Morphea; Pathogenesis; Susceptibility genes

Mesh:

Year:  2022        PMID: 35286696     DOI: 10.1007/978-3-030-92616-8_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  130 in total

1.  Risk factors for genital lichen sclerosus in men.

Authors:  M Bjekić; S Šipetić; J Marinković
Journal:  Br J Dermatol       Date:  2011-02       Impact factor: 9.302

2.  Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes.

Authors:  F Bernerd; A Sarasin; T Magnaldo
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease.

Authors:  R M Azurdia; G A Luzzi; I Byren; K Welsh; F Wojnarowska; P Marren; A Edwards
Journal:  Br J Dermatol       Date:  1999-01       Impact factor: 9.302

4.  Transforming growth factor-beta1 is a potent inhibitor of glutathione synthesis in the lung epithelial cell line A549: transcriptional effect on the GSH rate-limiting enzyme gamma-glutamylcysteine synthetase.

Authors:  K Arsalane; C M Dubois; T Muanza; R Bégin; F Boudreau; C Asselin; A M Cantin
Journal:  Am J Respir Cell Mol Biol       Date:  1997-11       Impact factor: 6.914

5.  Involvement of alphavbeta5 integrin in the establishment of autocrine TGF-beta signaling in dermal fibroblasts derived from localized scleroderma.

Authors:  Yoshihide Asano; Hironobu Ihn; Masatoshi Jinnin; Yoshihiro Mimura; Kunihiko Tamaki
Journal:  J Invest Dermatol       Date:  2006-05-04       Impact factor: 8.551

Review 6.  Oral lichen sclerosus-a review of clinical presentation, treatment, and clinical outcomes.

Authors:  Stephanie L Bevans; Jordan M Keeley; Naveed Sami
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2017-08-03

7.  Peristomal lichen sclerosus: the role of occlusion and urine exposure?

Authors:  F Al-Niaimi; C Lyon
Journal:  Br J Dermatol       Date:  2013-03       Impact factor: 9.302

8.  T cells reactive with the NC16A domain of BP180 are present in vulval lichen sclerosus and lichen planus.

Authors:  M Baldo; A Bailey; B Bhogal; R W Groves; G Ogg; F Wojnarowska
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-08-14       Impact factor: 6.166

Review 9.  Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis.

Authors:  I Badea; M Taylor; A Rosenberg; M Foldvari
Journal:  Rheumatology (Oxford)       Date:  2008-11-20       Impact factor: 7.580

10.  Segmental and generalized vitiligo: both forms demonstrate inflammatory histopathological features and clinical mosaicism.

Authors:  Venkat Ratnam Attili; Sasi Kiran Attili
Journal:  Indian J Dermatol       Date:  2013-11       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.